Search
for
Sort by
Research 601–630 of 1000+
- JAK inhibitors in dermatology: The promise of a new drug class
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Photobiomodulation for Skin Pigmentation Disorders: A Dual-Function Treatment
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Oral Tofacitinib in Refractory Pediatric Alopecia Areata
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Remission of Alopecia Areata Post-colectomy in a Patient with Crohn's Disease.
- Growth Factors and Microneedling in Alopecia Areata: A Narrative Review
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Upadacitinib for the treatment of alopecia areata – A case report
- Transcriptome analysis of frontal fibrosis alopecia revealed involvement of immune cells and ferroptosis
- Probiotics: An Adjuvant therapy for D-Galactose induced Alzheimer's disease
- Microarray Gene Expression Analysis of Lesional Skin in Canine Pemphigus Foliaceus